In the bustling realm of female health startups, London’s Daye emerges with a significant development. Founded by Valentina Milanova, the company has secured a new patent for its pioneering Organic Diagnostic & Menstrual Tampon. This innovation, focusing on performance and sustainability, promises to enhance the user experience while addressing key concerns within the market. Its patent recognition is a milestone not just for the company, but for the broader sector of gynaecological products emphasizing eco-friendly solutions.
Earlier efforts by Daye positioned the company among unique health enterprises aiming to disrupt the traditional tampon market. Historically, competition revolved around maximizing absorbency and comfort using synthetic fibers. Now, Daye’s product stands out by prioritizing organic, plastic-free materials. While conventional brands relied on synthetic components for efficiency, Daye introduces a protective sleeve to combat fibre shedding, along with innovative design features aimed at enhancing fluid absorption and user comfort.
What Sets Daye’s Product Apart?
The tampon’s design includes a dual-surface structure and a cupped tip for efficient absorption and reduced leakage. It’s also crafted with therapeutic coatings and employs a scalable production process, targeting sustainability and high performance. Milanova expressed confidence in the product’s ability to outperform existing synthetic fiber options while promoting eco-conscious practices. She stated,
“This is a major win for performance, sustainability, and patient experience — especially since absorbency is still one of the top reasons people hesitate to switch to organic.”
How Are the Funds Being Utilized?
Funds raised recently through the Bright Friday campaign have channeled into tackling critical women’s health issues. These initiatives involve creating non-hormonal treatments for endometriosis, exploring diagnostics via menstrual fluid, and researching heavy menstrual bleeding. Addressing these gaps intends to disseminate knowledge while innovating in healthcare solutions for women. Through strategic partnerships and financial support, Daye propels projects aiming at holistic females’ health improvements.
Daye’s collaboration with Wellbeing of Women exemplifies its commitment to bridging the gender health gap. The partnership capitalizes on Wellbeing of Women’s extensive background in funding research tied to women’s health challenges such as endometriosis, gynaecological cancers, and menstrual disorders. This collective effort underpins Daye’s mission to develop superior products and foster an informed ecosystem for female health.
Wellbeing of Women’s rich history includes significant contributions to women’s health advancements. They played a key role in establishing prenatal ultrasound usage and identifying HPV’s link to cervical cancer. The charity’s portfolio has led to comprehensive national health programs and vaccines diminishing cervical cancer rates. Such foundational work inspires Daye’s ongoing research and motivates its proactive stance in innovating and addressing women’s health head-on.
As the focus on sustainable and effective health products gains momentum, Daye’s recent patent acquisition marks a pivotal point. The growing attention toward sustainable solutions in health and diagnostics invites similar innovations, driving industry-wide transformations. The blend of rigorous research and strategic collaborations exemplifies a model for future ventures in women’s health innovation. Tackling entrenched issues like endometriosis and gynaecological cancers becomes a shared responsibility, fostering a more inclusive healthcare discourse.
